Thierry Chauche
Chief Financial Officer · Sagimet Biosciences Inc.
- 2026
- Jun 2, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thierry Chauche files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- George Kemble - $4.22M in SGMT purchases and sales in the last 12 months
- David Happel - $562K in SGMT purchases and sales in the last 12 months
- Elizabeth Rozek - $96K in SGMT purchases and sales in the last 12 months
- Eduardo Bruno Martins - $20K in SGMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thierry Chauche?
Thierry Chauche is a corporate insider, tracked as Chief Financial Officer of Sagimet Biosciences Inc. (SGMT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Thierry Chauche last file a Form 4?
The most recent primary Form 4 on record is dated 2 June 2026, one of 3 filings going back to 2026.
Has Thierry Chauche been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($7K) across all tracked filings.
